Evaluation of a catch-up strategy for the vaccination in patients with hepatitis C virus
Rev Esp Enferm Dig. 2024 Mar 19. doi: 10.17235/reed.2024.10386/2024. Online ahead of print.ABSTRACTVaccination in patients with advanced chronic liver disease (ACLD) is an essential part of their comprehensive healthcare. These individuals may have impaired phagocytic function and diminished production of opsonizing antibodies, resulting in increased susceptibility to bacterial infections, particularly pneumococcal pneumonia. Similarly, there is an increased risk of fulminant hepatitis due to hepatitis A and B viruses. The Ministry of Health updated specific vaccination recommendations for this group in 2018.PMID:38501772 | DOI:10.17235/reed.2024.10386/2024
Source: Revista Espanola de Enfermedades Digestivas - Category: Gastroenterology Authors: Mar ía Fernández-Prada Andrea Fraga-P érez Paula Cienfuegos-Gonz ález Mar ía José Zapico-Baragaño Jos é Miguel Brea-Corral Adri án Huergo-Fernández Source Type: research
More News: Gastroenterology | Hepatitis | Hepatitis A | Hepatitis C | Hepatitis Vaccine | Liver | Liver Disease | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Urology & Nephrology | Vaccines